ACA taxes still on Congress's radar

Republican hopes to repeal and/or replace the Affordable Care Act (ACA) petered out in July, but healthcare industry groups still want Congress to delay the law’s health insurance and medical device taxes. The problem, according to Axios report Caitlin Owens, is finding the legislative vehicle to do so.

Congress already has plenty on its plate when lawmakers return to Capitol Hill after the August recess, including healthcare priorities like the reauthorization of the Children’s Health Insurance Program (which could get pushed back to December) and crafting a short-term ACA stabilization bill.

While there has been bipartisan support in the past on delaying these two taxes, the bitterness over the repeal-and-replace debate makes anything related to the law hard to discuss.

"It is a have-to-get-done that's really hard to get done," said one lobbyist.

Read the full article at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.